BC
CORT icon

Burney Company’s Corcept Therapeutics CORT Stock Holding History

Burney Company’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
24,156
-21,623
-47% -$1.31M 0.06% 233
2026
Q1 		$1.85M Sell
45,779
-178,058
-80% -$6.66M 0.06% 228
2025
Q4 		$7.79M Sell
223,837
-6,928
-3% -$544K 0.24% 91
2025
Q3 		$19.2M Sell
230,765
-19,381
-8% -$1.4M 0.61% 35
2025
Q2 		$18.4M Sell
250,146
-16,251
-6% -$1.18M 0.62% 40
2025
Q1 		$30.4M Sell
266,397
-207,424
-44% -$12.6M 1.11% 14
2024
Q4 		$23.9M Buy
473,821
+39,657
+9% +$2.08M 0.84% 24
2024
Q3 		$20.1M Buy
434,164
+17,366
+4% +$617K 0.71% 30
2024
Q2 		$13.5M Sell
416,798
-14,840
-3% -$407K 0.52% 45
2024
Q1 		$10.9M Buy
431,638
+12,402
+3% +$293K 0.41% 62
2023
Q4 		$13.6M Buy
419,236
+17,973
+4% +$494K 0.57% 34
2023
Q3 		$10.9M Buy
401,263
+115,006
+40% +$3.33M 0.51% 49
2023
Q2 		$6.37M Sell
286,257
-612
-0.2% -$14.1K 0.29% 91
2023
Q1 		$6.21M Sell
286,869
-9,452
-3% -$207K 0.31% 91
2022
Q4 		$6.02M Sell
296,321
-94,959
-24% -$2.38M 0.3% 95
2022
Q3 		$10M Buy
391,280
+50,792
+15% +$1.36M 0.55% 46
2022
Q2 		$8.1M Sell
340,488
-9,492
-3% -$207K 0.43% 63
2022
Q1 		$7.88M Sell
349,980
-1,596
-0.5% -$34K 0.36% 80
2021
Q4 		$6.96M Sell
351,576
-31,600
-8% -$641K 0.3% 100
2021
Q3 		$7.54M Sell
383,176
-3,432
-0.9% -$71.8K 0.35% 84
2021
Q2 		$8.51M Buy
386,608
+8,781
+2% +$195K 0.4% 74
2021
Q1 		$8.99M Buy
377,827
+9,796
+3% +$262K 0.44% 67
2020
Q4 		$9.63M Buy
368,031
+21,573
+6% +$455K 0.53% 54
2020
Q3 		$6.03M Buy
346,458
+79,649
+30% +$1.27M 0.37% 79
2020
Q2 		$4.49M Buy
+266,809
New +$3.75M 0.29% 104

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Burney Company's CORT Position: Q2 2026 in Review

Burney Company reduced its Corcept Therapeutics (CORT) stake by 47% in Q2 2026, selling an estimated $1.31M and leaving 24,156 shares worth $2.1M. The position accounts for 0.06% of the portfolio, ranked #233.

Burney Company first reported a position in CORT in Q2 2020 and has held it in 25 quarters since. The position peaked at $30.4M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Burney Company held 24,156 shares of Corcept Therapeutics worth $2.1M as of Q2 2026.
  • Burney Company sold 21,623 Corcept Therapeutics shares in Q2 2026, an estimated $1.31M.
  • Corcept Therapeutics made up 0.06% of Burney Company's portfolio in Q2 2026, its #233 holding.
  • Burney Company first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Burney Company's Corcept Therapeutics position peaked at $30.4M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.